Effectiveness of Buddhist Monks in Providing Cognitive Behavior Therapy (Add-CBT)

October 12, 2012 updated by: Nahathai Wongpakaran, Chiang Mai University

A Randomized Controlled Trial of Cognitive Behavior Therapy Provided by Buddhist Monks vs. Treatment as Usual in the Treatment of Late Life-depression

This research is to study the effectiveness of cognitive behavioral therapy-CBT and Psychotherapy by trained buddhist monks. There are generally accepted that both cognitive and Buddhist concepts are related. This randomized controlled trial is to study the elderly participants who suffer major depressive disorder according to DSM-IV. The subjects will be divided into two groups. The experimental group will receive 12 sessions of CBT 2 times per week for 6 weeks in addition to usual treatment. The control group will receive treatment as usual and general conversation (non-CBT) with monks. Pretreatment factors (such as attachment style, interpersonal factors) of both therapist monks and patient participants will be studied.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

62

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Chiang Mai, Thailand, 50200
        • Geriatric clinic, Maharaj Nakorn Chiang Mai Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years to 95 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Meet criteria for Major depressive disorder
  • receiving antidepressant

Exclusion Criteria:

  • presence of intense suicidal intent behaviors that require inpatient admission
  • history of alcohol or drug dependence
  • presence of hallucinations or delusions
  • currently receiving electroconvulsive therapy or repetitive-transcranial magnetic stimulation,
  • patients' involvement in other clinical trials.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: SINGLE_GROUP
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: TAU plus Cognitive-behavioral Therapy
Participants randomized to this group will receive treatment as usual plus cognitive behavioral therapy (CBT) provided by trained Buddhist monks.
Treatment as usual (TAU)is defined as the routine care provided to each individual patient at the geriatric psychiatry clinic of Maharaj Nakorn Chiang Mai Hospital.
Other Names:
  • TAU
Cognitive behavioral therapy(CBT)includes psychoeducational components combined with cognitive interventions targeted at challenging negative automatic thoughts.
SHAM_COMPARATOR: TAU plus routine counselling
Participants randomized into this group will receive treatment as usual (TAU) plus plus routine psychological support from non-CBT monks.
Treatment as usual (TAU)is defined as the routine care provided to each individual patient at the geriatric psychiatry clinic of Maharaj Nakorn Chiang Mai Hospital.
Other Names:
  • TAU

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evidence of clinically depression confirmed by clinician
Time Frame: 2 months after the end of the intervention
Depression will be assessed by HAMD-7 (McIntyre, 2005)
2 months after the end of the intervention
Depression- self report
Time Frame: 2 month after the end of the inetrvention
depression will be assessed by Geriatric Depression Scale (GDS)(Shiekh & Yesavage, 1986)
2 month after the end of the inetrvention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dimensional psychological distress (anxiety, depression,and somatization)
Time Frame: week 6, 12, 20
anxiety, depression,and somatization symptom will be assessed by the Core symptom index (CSI) (Wongpakaran, unpublished),
week 6, 12, 20
Dimensional psychological distress ( perception of stress)
Time Frame: Week 6, 12, 20
Perception of stress will be assessed by Perceived Stress Scale-10 (PSS-10) (Cohen 1983 ; Wongpakaran, 2010)
Week 6, 12, 20

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
working alliance
Time Frame: after session 3, 6, and 12
Working alliance will be assessed by the Helping Alliance Questionnaire (HAQ)(Luborsky, 1996)
after session 3, 6, and 12
Pretreatment measure (attachment)
Time Frame: at baseline
The part includes participants' attachment which will be assessed by the revised Experience of Close Relationships Questionnaire (ECR-R 18)(Wongpakaran, 2012)
at baseline
Pretreatment measure (interpersonal problems)
Time Frame: at baseline
Interpersonal problems will be assessed by the inventory of interpersonal problems(Horowitz, 2000)
at baseline
Pretreatment measure(neuroticism)
Time Frame: at baseline
Neuroticism will be assessed by the Neuroticsm Inventory (Wongpakaran,unpublished)
at baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nahathai - Wongpakaran, M.D., Chiang Mai University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2012

Primary Completion (ANTICIPATED)

October 1, 2013

Study Completion (ANTICIPATED)

October 1, 2013

Study Registration Dates

First Submitted

October 8, 2012

First Submitted That Met QC Criteria

October 12, 2012

First Posted (ESTIMATE)

October 15, 2012

Study Record Updates

Last Update Posted (ESTIMATE)

October 15, 2012

Last Update Submitted That Met QC Criteria

October 12, 2012

Last Verified

October 1, 2012

More Information

Terms related to this study

Other Study ID Numbers

  • 918

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Major Depressive Disorder

Clinical Trials on Treatment as usual

Subscribe